von Willebrand factor expression in osteosarcoma metastasis

Womer, 1991, The cellular biology of bone tumors, Clin Orthop Relat Res, 262, 12, 10.1097/00003086-199101000-00003 Eilber, 1987, Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial, J Clin Oncol, 5, 21, 10.1200/JCO.1987.5.1.21 Provisor, 1997, Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group, J Clin Oncol, 15, 76, 10.1200/JCO.1997.15.1.76 Souhami, 1997, Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup, Lancet, 350, 911, 10.1016/S0140-6736(97)02307-6 Vogelstein, 1993, The multistep nature of cancer, Trends Genet, 9, 138, 10.1016/0168-9525(93)90209-Z Ladanyi, 2000, Molecular pathology and molecular pharmacology of osteosarcoma, Pediatr Pathol Mol Med, 19, 391, 10.1080/15513810009168647 Boehm, 2000, Cytogenetic findings in 36 osteosarcoma specimens and a review of the literature, Pediatr Pathol Mol Med, 19, 359, 10.1080/15513810009168645 Gokgoz, 2001, Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma, Cancer, 92, 2181, 10.1002/1097-0142(20011015)92:8<2181::AID-CNCR1561>3.0.CO;2-3 Wunder, 1999, Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas, Oncogene, 18, 783, 10.1038/sj.onc.1202346 Fidler, 1990, Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture, Cancer Res, 50, 6130 Sadler, 1998, Biochemistry and genetics of von Willebrand factor, Annu Rev Biochem, 67, 395, 10.1146/annurev.biochem.67.1.395 Furlan, 1996, Von Willebrand factor: molecular size and functional activity, Ann Hematol, 72, 341, 10.1007/s002770050184 Ruggeri, 1993, von Willebrand factor, FASEB J, 7, 308, 10.1096/fasebj.7.2.8440408 McComb, 1982, Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue, J Histochem Cytochem, 30, 371, 10.1177/30.4.6801111 Weidner, 1995, Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors, Breast Cancer Res Treat, 36, 169, 10.1007/BF00666038 Hejna, 1999, Inhibition of metastases by anticoagulants, J Natl Cancer Inst, 91, 22, 10.1093/jnci/91.1.22 Mehta, 1984, Potential role of platelets in the pathogenesis of tumor metastasis, Blood, 63, 55, 10.1182/blood.V63.1.55.55 Gasic, 1973, Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease, Int J Cancer, 11, 704, 10.1002/ijc.2910110322 Karpatkin, 1988, Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo, J Clin Invest, 81, 1012, 10.1172/JCI113411 Nieswandt, 1999, Lysis of tumor cells by natural killer cells in mice is impeded by platelets, Cancer Res, 59, 1295 Dahlin, 1988, Grading in bone tumors, 35 Hopyan, 1999, Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours, J Orthop Res, 17, 633, 10.1002/jor.1100170503 Liang, 1992, Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction, Science, 257, 967, 10.1126/science.1354393 Bauer, 1993, Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR), Nucleic Acids Res, 21, 4272, 10.1093/nar/21.18.4272 Mancuso, 1991, Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction, Biochemistry, 30, 253, 10.1021/bi00215a036 Wunder, 2000, MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study, J Clin Oncol, 18, 2685, 10.1200/JCO.2000.18.14.2685 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Hlatky, 2002, Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us, J Natl Cancer Inst, 94, 883, 10.1093/jnci/94.12.883 Ohsawa, 1995, Angiogenesis in malignant fibrous histiocytoma, Oncology, 52, 51, 10.1159/000227427 Tomlinson, 1999, Different patterns of angiogenesis in sarcomas and carcinomas, Clin Cancer Res, 5, 3516 Yudoh, 2001, Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas, Br J Cancer, 84, 1610, 10.1054/bjoc.2001.1837 Mantadakis, 2001, Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma, Am J Pediatr Hematol Oncol, 23, 286, 10.1097/00043426-200106000-00010 Zanetta, 2000, Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis, Int J Cancer, 85, 281, 10.1002/(SICI)1097-0215(20000115)85:2%3C281::AID-IJC21%3E3.0.CO;2-3 Aird, 1997, Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment, J Cell Biol, 138, 1117, 10.1083/jcb.138.5.1117 Yamamoto, 1998, Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo, Blood, 92, 2791, 10.1182/blood.V92.8.2791 Kohlberger, 1996, Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods, Am J Clin Pathol, 105, 705, 10.1093/ajcp/105.6.705 Martin, 1997, Examining the technique of angiogenesis assessment in invasive breast cancer, Br J Cancer, 76, 1046, 10.1038/bjc.1997.506 Weidner, 1995, Intratumor microvessel density as a prognostic factor in cancer, Am J Pathol, 147, 9 Goddard, 2002, A computer image analysis system for microvessel density measurement in solid tumours, Angiogenesis, 5, 15, 10.1023/A:1021518315757 Chantrain, 2003, Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections, J Histochem Cytochem, 51, 151, 10.1177/002215540305100203 Shevde, 2003, Metastasis suppressor pathways—an evolving paradigm, Cancer Lett, 198, 1, 10.1016/S0304-3835(03)00304-5 Hynes, 2003, Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants or both?, Cell, 113, 821, 10.1016/S0092-8674(03)00468-9 Kang, 2003, A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, 3, 537, 10.1016/S1535-6108(03)00132-6 Nierodzik, 1992, Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo, Cancer Res, 52, 3267 Nierodzik, 1991, Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo, J Clin Invest, 87, 229, 10.1172/JCI114976 Chiang, 1995, The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells, Br J Cancer, 71, 265, 10.1038/bjc.1995.54 Nierodzik, 1995, Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo, Thromb Haemost, 74, 282, 10.1055/s-0038-1642691 Chopra, 1988, Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation, Cancer Res, 48, 3787 Boukerche, 1989, Platelet–melanoma cell interaction is mediated by the glycoprotein IIb–IIIa complex, Blood, 74, 658, 10.1182/blood.V74.2.658.658 Nierodzik, 1994, Role of platelet integrin GPIIb-GPIIIa, fibronectin, von Willebrand factor, and thrombin in platelet–tumor interaction in vitro and metastasis in vivo, Semin Hematol, 31, 278 Kitagawa, 1989, Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells, Cancer Res, 49, 537 Chopra, 1992, Is there a role for the tumor cell integrin alpha IIb beta 3 and cytoskeleton in tumor cell–platelet interaction?, Clin Exp Metast, 10, 125, 10.1007/BF00114589 Mehta, 1987, Effect of human tumor cells on platelet aggregation: potential relevance to pattern of metastasis, Cancer Res, 47, 3115 Clezardin, 1991, Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet–osteosarcoma cell interaction, Cancer Res, 51, 2621 Clezardin, 1993, Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells, Cancer Res, 53, 4695 Davis, 1994, Prognostic factors in osteosarcoma: a critical review, J Clin Oncol, 12, 423, 10.1200/JCO.1994.12.2.423